Deal Details

NanoString Completes $230 Million Follow-On Offering

Healthcare

NanoString follow-on offering

Summary

NanoString Technologies, Inc. (“NanoString” or “the Company”) (NASDAQ:NSTG) recently completed an underwritten public offering of 5,750,000 shares of its common stock at a price to the public of $40.00 per share, including the underwriters’ option to purchase an additional 750,000 shares of common stock. The gross proceeds to NanoString from the offering are expected to be approximately $230.0 million before deducting the underwriting discounts and commissions. The transaction was upsized from the previously announced offering size of $150.0 million of common stock.

Baird served as lead manager on the offering.

About

NanoString Technologies, Inc. engages in the development and commercialization of instrument and services for profiling of genes and proteins from tissue samples. NanoString offers GeoMx Digital Spatial Profiler, nCounter Systems, analysis solutions, gene expression panels, Vantage 3D Assays, miRNA Assays, custom solutions and Sample Prep and nCounter Consumables. The Company was founded on June 20, 2003 and is headquartered in Seattle, Washington.

Healthcare

NanoString follow-on offering